| 2024/04/19 08:10:24 | |
|---|---|
| Price | |
| 35.67 EUR | |
| Difference | 2.21% (0.77) |
General attributes
| ISIN | JP3160400002 |
| Symbol | 4523 |
| Exchange | Duesseldorf |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 10,489 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | 35.66 EUR (140) |
| Ask (Ask size) | 36.26 EUR (140) |
| Open | 35.67 EUR |
| High | 35.67 EUR |
| Low | 35.67 EUR |
| Close (prev. day) | 34.90 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: EISAI CO. LTD. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/19 08:10:24 | |
|---|---|
| Price | |
| 35.67 EUR | |
| Difference | 2.21% (0.77) |
General attributes
| ISIN | JP3160400002 |
| Symbol | 4523 |
| Exchange | Duesseldorf |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 10,489 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | 35.66 EUR (140) |
| Ask (Ask size) | 36.26 EUR (140) |
| Open | 35.67 EUR |
| High | 35.67 EUR |
| Low | 35.67 EUR |
| Close (prev. day) | 34.90 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -32.81% | -32.65% | -36.55% |
| Perf (abs.) | -17.04 | -16.92 | -20.10 |
| Beta | 0.51 | 0.55 | 0.61 |
| Volatility | 27.00 | 32.85 | 47.70 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 35.94 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 37.61 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 41.48 EUR (5) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 49.78 EUR (4) |
| YTD High | date | 47.27 EUR (2024/01/11) |
| YTD Low | date | 34.90 EUR (2024/04/18) |
| 52 Weeks High | date | 73.68 EUR (2023/06/09) |
| 52 Weeks Low | date | 34.90 EUR (2024/04/18) |
All listings for EISAI CO. LTD.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/18 | 22:26 | 35.11 EUR | 0.01 | 3 |
| Tokyo Stock Exchange | 2024/04/18 | 08:00 | 5,824.00 JPY | 65.38 | 3,268 |
| Stuttgart | 2024/04/19 | 08:03 | 35.76 EUR | 0.00 | 1 |
| Munich | 2024/04/19 | 08:14 | 35.84 EUR | 0.00 | 1 |
| Hanover | 2024/04/19 | 08:00 | 35.49 EUR | 0.00 | 1 |
| Frankfurt | 2024/04/19 | 08:26 | 35.49 EUR | 0.00 | 1 |
| FINRA other OTC Issues | 2024/04/18 | 18:03 | 37.53 USD | 0.08 | 7 |
| Duesseldorf | 2024/04/19 | 08:10 | 35.67 EUR | 0.00 | 1 |
| Berlin | 2024/04/19 | 08:15 | 35.84 EUR | 0.00 | 1 |
Company Logo
Contact Details
| EISAI CO. LTD. |
| - - |
| 4-6-10 Koishikawa, Bunkyo-Ku - 112-8088 Tokyo |
| Telefon: +81-3-3817-3700 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: EISAI CO. LTD. | |
Company Profile
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan. |
Members of Management Board
| Haruo Naito | Chairman of Managing Board |
| Akiko Nakahama | Member of Executive Committee |
| Gary Hendler | Member of Executive Committee |
| Ivan Cheung | Member of Executive Committee |
| Kazuhiko Tamura | Member of Executive Committee |
| Keisuke Naito | Member of Executive Committee |
| Kenta Takahashi | Member of Executive Committee |
| Lynn Kramer | Member of Executive Committee |
| Masatomi Akana | Member of Executive Committee |
| Mitsuo Kosaka | Member of Executive Committee |
| Mitsuru Shomon | Member of Executive Committee |
| Sayoko Sasaki | Member of Executive Committee |
| Shin Ujiie | Member of Executive Committee |
| Shohei Kanazawa | Member of Executive Committee |
| Takashi Owa | Member of Executive Committee |
| Tatsuyuki Yasuno | Member of Executive Committee |
| Terushige Iike | Member of Executive Committee |
| Teruyuki Masaka | Member of Executive Committee |
| Toshitaka Asano | Member of Executive Committee |
| Yanhui Feng | Member of Executive Committee |
| Yasushi Okada | Member of Executive Committee |
Board of directors
| Clive Thornley | Member of Supervisory Board |
| Fumihiko Ike | Member of Supervisory Board |
| Hideki Hayashi | Member of Supervisory Board |
| Hideyo Uchiyama | Member of Supervisory Board |
| Hiroyuki Kato | Member of Supervisory Board |
| Ryota Miura | Member of Supervisory Board |
| Toru Moriyama | Member of Supervisory Board |
| Yoshiteru Kato | Member of Supervisory Board |
| Yuko Yasuda | Member of Supervisory Board |
| Yumiko Miwa | Member of Supervisory Board |